top of page
![shutterstock_1467879026.jpg](https://static.wixstatic.com/media/3c3532_d6887c9359044165b1154044a5dfcb23~mv2.jpg/v1/fill/w_980,h_653,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/3c3532_d6887c9359044165b1154044a5dfcb23~mv2.jpg)
Pharmaceutical Resources
Pharmaceutical Resources
Not only is it important to learn about all of the melanoma treatment options after a diagnosis, but you should also learn about all of the resources available, including those from pharmaceutical companies that manufacture your drug. Below are a few of the most commonly used treatments in melanoma and links to help you if your melanoma diagnosis becomes a financial burden on you and your family. We encourage you to take advantage of some or all of these resources.
-
Amgen’s Assist Program® (Imlygic®)
-
ArrayACTS™ (Braftovi™; Mektovi®)
-
Bristol-Myers Squibb’s Access Support® (Yervoy®; Opdivo®)
-
Genentech’s Access to Care Foundation® (Zelboraf®; Cotellic®)
-
Novartis’ Patient Assistance Now® (Tafinlar®; Mekinist®)
-
Merck’s Access Program® (Keytruda®)
bottom of page